Why Medicare's $50 GLP-1 Copay Is a BMI Calculator's Biggest Test
The Medicare GLP-1 Bridge starts July 2026. I ran the numbers on who qualifies, what BMI thresholds mean, and why this changes everything.
I Tried Oral GLP-1 Foundayo for 30 Days. The Spreadsheet Doesn't Lie.
Eli Lilly's Foundayo hit the market in April 2026. I tracked weight, BMI, side effects, and cost for 30 days. Here's the raw data.
Smart Rings vs Bathroom Scales: A 60-Day Data Experiment
I wore a smart ring and stepped on a smart scale every morning for 60 days. The correlation was weaker than I expected.
Why Your Wearable's Glucose Trend Is Probably Wrong
Non-invasive glucose monitoring is the hottest wearable feature of 2026. I tested the claims against a real CGM. The results were messy.
GLP-1 Eligibility by BMI: Who Actually Qualifies?
BMI 27, 30, or 35? I parsed the Medicare GLP-1 Bridge criteria, FDA labels, and real-world prescribing data. The spreadsheet is ugly.
I Tracked My Heart Rate at 6 Austin Coffee Shops
From Houndstooth to Mozart's, I sat in six Austin coffee shops with my wearable running. The heart rate data says more about ambiance than caffeine.